Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 3UNKNOWN 1NETWORK 1INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 4Urothelial Cancer 1Pancreatic Adenocarcinoma 1Neurotoxicity Syndromes 1Neoplasms 1Neoplasm Metastasis 1Gallbladder Neoplasms 1Cholangiocarcinoma 1Breast Neoplasms 1Anatomic Stage II Breast Cancer AJCC v8 1Advanced Pancreatic Cancer 1

Interventions

paricalcitol 1Gemcitabine 1130-nm albumin-bound paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Advanced Pancreatic Cancer × 130-nm albumin-bound paclitaxel × Clear all
NCT04617067 2024-03-06

Paricalcitol Trial: Phase II, Open Label Clinical Trial of Paricalcitol in Combination With Gemcitabine/ Nab-Paclitaxel Therapy in Advanced Pancreatic Cancer

Cancer Trials Ireland

Phase 2 Completed
15 enrolled
Gastrointestinal

Advanced Pancreatic Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡